Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -463,661 | -328,066 | -239,476 | -186,479 | -87,006 |
| Depreciation Amortization | 36,494 | 24,402 | 11,756 | 8,405 | 3,943 |
| Accounts receivable | -6,071 | -7,756 | -2 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,435 | -987 | 1,767 | 1,745 | -185 |
| Other Working Capital | -38,001 | -50,257 | 104,921 | -306 | 31,615 |
| Other Operating Activity | 105,630 | 74,884 | 37,510 | 18,021 | 6,234 |
| Operating Cash Flow | $-359,174 | $-287,780 | $-83,524 | $-158,614 | $-45,399 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 480 | 230,608 | -231,946 | N/A |
| PPE Investments | -13,695 | -11,955 | -37,059 | -39,798 | -5,831 |
| Net Acquisitions | 277,104 | 1,844 | N/A | N/A | -2,600 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 595 |
| Purchase Sale Intangibles | -3,350 | -597 | -300 | N/A | -904 |
| Other Investing Activity | -3,350 | -597 | -300 | 0 | -904 |
| Investing Cash Flow | $260,059 | $-10,228 | $193,249 | $-271,744 | $-8,740 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 6,400 |
| Debt Repayment | -4,440 | -766 | -90 | -12,798 | -77 |
| Common Stock Issued | 300,417 | 128,093 | 143,711 | 462,901 | N/A |
| Other Financing Activity | 8,143 | 12,806 | 10,724 | 8,437 | 239,812 |
| Financing Cash Flow | $304,120 | $140,133 | $154,345 | $458,540 | $246,135 |
| Exchange Rate Effect | -3,406 | 188 | -307 | N/A | N/A |
| Beginning Cash Position | 401,425 | 559,112 | 295,349 | 267,167 | 75,171 |
| End Cash Position | 603,024 | 401,425 | 559,112 | 295,349 | 267,167 |
| Net Cash Flow | $201,599 | $-157,687 | $263,763 | $28,182 | $191,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -359,174 | -287,780 | -83,524 | -158,614 | -45,399 |
| Capital Expenditure | -13,695 | -11,955 | -37,059 | -39,798 | -5,831 |
| Free Cash Flow | -372,869 | -299,735 | -120,583 | -198,412 | -51,230 |